Biotechnology
A corporate and investor platform bringing biotech BioSenic together with investors and patients. As a public company rebuilding shareholder confidence, it needed one platform with real-time share data. Now it runs an investor relations channel with live pricing.
Corporate & Investor Platform
BioSenic needed a single platform serving very different audiences at once, from investors evaluating share performance to visitors and patients researching its science.
Devatwork built a Drupal-based site with clearly separated Investor, Products, and Clinical Studies sections under one architecture.
As a publicly listed company, BioSenic needed to display its own real-time share price rather than routing visitors to a third-party exchange page.
We integrated a live stock market feed directly into the platform.
Different audiences needed different levels of access to the same platform, from public visitors to internal staff managing content.
We built comprehensive user, role, and permission management across the site.
The platform needed to keep evolving with the business, adding or adjusting modules over time without a full rebuild each time.
Devatwork designed a modular architecture and has provided SLA-based technical support since launch.
Result
BioSenic launched its rebranded public platform with a working investor relations channel from day one, including a live share price, an essential step at a time when the company urgently needed to rebuild public and shareholder confidence. Its modular architecture also enabled BioSenic to add and update content independently after handover.
Next project
One Platform, Every Stakeholder
Whether you're serving investors, patients, or the public, we build platforms that bring it all together.